|
MYCO |
FORM 5 - QUARTERLY LISTING STATEMENT |
Quarterly Listing Statement |
30/11/2020 |
 Open Filing (1.02 MB) |
|
STX |
Form 7 - Monthly Progress Report - October 2020 |
Monthly Progress Report |
30/11/2020 |
Open Filing (176.16 KB) |
|
MYCO |
Form 52-109FV2 CFO Certification |
Other |
30/11/2020 |
Open Filing (102.58 KB) |
|
MYCO |
Form 52-109FV2 CEO Certification |
Other |
30/11/2020 |
Open Filing (102.98 KB) |
|
MYCO |
MYDECINE INNOVATIONS GROUP INC. MANAGEMENT DISCUSSION AND ANALYSIS PERIOD ENDED SEPTEMBER 30, 2020 AND 2019 |
MD&A (Management Discussion and Analysis) |
30/11/2020 |
Open Filing (386.61 KB) |
|
MYCO |
MYDECINE INNOVATION GROUP INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS PERIOD ENDED SEPTEMBER 30, 2020 AND 2019 |
Interim Financial Statements |
30/11/2020 |
Open Filing (273.32 KB) |
|
PBT.U |
CSE Form 5 Quarterly Listing Statement For The Quarter Ended September 30, 2020 |
Listing Statement |
30/11/2020 |
Open Filing (200.33 KB) |
|
PBT.U |
MD&A for the three and six months ended September 30, 2020 |
MD&A (Management Discussion and Analysis) |
30/11/2020 |
Open Filing (487.14 KB) |
|
EPY |
Interim MD&A Statements - ePlay |
MD&A (Management Discussion and Analysis) |
30/11/2020 |
Open Filing (190.35 KB) |
|
EPY |
Interim Financial Statements - ePlay |
Interim Financial Statements |
30/11/2020 |
Open Filing (375.91 KB) |
